Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 5, 2006, Pages 559-564

  Kanavaki, S ^a   Mantadakis, E ^b   Nikolaou, S ^a   Papavassiliou, A ^a   Karambela, S ^a   Anagnostou, S ^a   Falagas, M E ^c   Samonis, George ^b,d  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

Greece; Immigration; Isoniazid; Resistance; Rifampicin; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; GREECE; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SPUTUM ANALYSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; EMIGRATION AND IMMIGRATION; FEMALE; GREECE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; USSR;

EID: 33646364077     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization. Forty-fourth World Health Assembly. WHA44/1991/REC/1.t Geneva, Switzerland: WHO, 1991.
2. Esteban J, Granizo J J, Alvarez-Castillo M C, Soriano F. Drug resistance among Mycobacterium tuberculosis strains in immigrants: is there a real threat everywhere? Clin Microbiol Infect 2004; 10: 335-336.
3. Hamburg M A, Frieden T R. Tuberculosis transmission in the 1990s. N Engl J Med 1994; 330: 1750-1751.
4. Raviglione M C, Snider D E Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
5. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-1303.
6. Laserson K F, Iademarco M F. Profiling drug resistance in immigrants with tuberculosis. Chest 2000; 117: 623-625.
7. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545.
8. Mahmoudi A, Iseman M D. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68.
9. Khan K, Muennig P, Behta M, Zivin J G. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med 2002; 347: 1850-1859.
10. Rieder H L, Zellweger J P, Raviglione M C, Keizer S T, Migliori G B. Tuberculosis control in Europe and international migration. Eur Respir J 1994; 7: 1545-1553.
11. Glynn J R. Resurgence of tuberculosis and the impact of HIV infection. Br Med Bull 1998; 54: 579-593.
12. Viljanen M K, Vyshnevskiy B I, Otten T F, et al. Survey of drug resistant tuberculosis in Northwestern Russia from 1984 through 1994. Eur J Clin Microbiol Infect Dis 1998; 17: 177-183.
13. Gilad J, Borer A, Riesenberg K, Peled N, Schlaeffer F. Epidemiology and ethnic distribution of multi-drug resistant tuberculosis in Southern Israel, 1992-1997: the impact of immigration. Chest 2000; 117: 738-743.
14. EuroTB (InVS/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2002, Saint-Maurice, France: Institut de veille sanitaire, December 2004. www.eurotb.org
15. World Health Organization. Drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1999-2002. Third global report. Geneva, Switzerland: WHO, 2004.
16. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Report 2: prevalence and trends. Geneva, Switzerland: WHO, 2000.
17. Raviglione M C, Gupta R, Dye C M, Espinal M A. The burden of drug-resistant tuberculosis and mechanisms for its control. Ann N Y Acad Sci 2001; 953: 88-97.
18. Lillebaek T, Andersen A B, Bauer J, et al. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol 2001; 39: 855-861.
19. Niemann S, Rusch-Gerdes S, Richter E. IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995. J Clin Microbiol 1997; 35: 3015-3020.
20. Mostrom P, Gordon M, Sola C, Ridell M, Rastogi N. Methods used in the molecular epidemiology of tuberculosis. Clin Microbiol Infect 2002; 8: 694-704.
21. Barnes P F, Cave M D. Molecular epidemiology of tuberculosis. N Engl J Med 2003; 349: 1149-1156.